Pharmaceutical CAS 154229-19-3 Abiraterone Purity Abiraterone Acetate Powder Raw Powder Abiraterone

• Customization: Available
• Powder: Yes
• Customized: Customized
• Model NO.: D-sung Abiraterone
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Elderly, Children, Adult
• State: Powder
• Purity: >99%
• Product Name: Abiraterone
• Name: Abiraterone Powder
• Appearance: White Powder
• Color: White
• Grade: Pharmaceutical Grade
• Assay: HPLC 99%
• Application: Pharmaceutical
• Specific: COA
• Test Method: HPLC
• Shelf Life: 2 Years
• CAS No.: 154229-19-3
• Mf: C24h31no
• MW: 349.518
• Density: 1.14
• Melting Point: 226.0 to 230.0 Deg-C
• Transport Package: Negotiable
• Specification: 99%
• Trademark: D-sung
• Origin: Shaanxi Xi′an
• Production Capacity: 500kg/Month

Product Description

Pharmaceutical CAS 154229-19-3 Abiraterone Purity Abiraterone Acetate Powder Raw Powder Abiraterone

Product Description

Product Details

Product name	Abiraterone
Appearance	White powder
CAS NO.	154229-19-3
MF	C24H31NO
MW	349.518

Abiraterone acetate, the active ingredient of ZYTIGA is the acetyl ester of abiraterone. Abiraterone is an inhibitor of CYP17
(17α-hydroxylase/C17,20-lyase). Each ZYTIGA tablet contains 250 mg of abiraterone acetate. Abiraterone acetate is designated chemically
as (3β)-17-(3-pyridinyl)androsta-5,16-dien-3-yl acetate
Abiraterone acetate is a white to off-white, non-hygroscopic, crystalline powder. Its molecular formula is C26H33NO2and it has a
molecular weight of 391.55. Abiraterone acetate is a lipophilic compound with an octanol-water partition coefficient of 5.12 (Log P)
and is practically insoluble in water. The pKa of the aromatic nitrogen is 5.19.
Inactive ingredients in the tablets are colloidal silicon dioxide, croscarmellose sodium, lactose monohydrate, magnesium stearate,microcrystalline cellulose, povidone, and sodium lauryl sulfate.

Application&Function

Abiraterone is a drug used in castration-resistant prostate cancer. It is formulated as the prodrug abiraterone acetate.
Abiraterone can be used as a prostate cancer drug treatment. Abiraterone is a inhibitor of CYP17. It can be used to treat CRPC.

 

Abiraterone is used as pharmaceutical raw material.
Potential agent for the treatment of prostatic cancer.

Specification